Related Experiment Video
Updated: May 2, 2026
Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock
Published on: June 6, 2011
Understanding innovations in the evolving practice of blood and crystalloid cardioplegia
K P Bhakri1, J Mulholland2, P P Punjabi2
1National Heart & Lung Institute, Imperial College London, London, UK kunalb16@yahoo.co.uk.
Insights
Cardioplegia solution enhances cardiac surgery safety by protecting the heart muscle during procedures. Evolving research explores new methods like polarized arrest for improved myocardial protection in complex patients.
Area of Science:
- Cardiology
- Cardiac Surgery
- Cardiovascular Research
Background:
- Cardioplegia solution is crucial for cardiac surgery safety.
- It protects the myocardium by inducing diastolic arrest, reducing energy demands and preventing ischemic and reperfusion injury.
Purpose of the Study:
- To summarize the evolution of cardioplegia understanding.
- To discuss myocardial protection strategies in light of changing patient demographics and complex cardiac conditions.
- To introduce the concept of polarized arrest for enhanced myocardial protection.
Main Methods:
- Literature review and synthesis of existing research on cardioplegia.
- Comparison of blood and crystalloid cardioplegia based on biochemical and physiological data.
- Discussion of recent patient demographic shifts impacting cardiac surgery.
Main Results:
- Cardioplegia minimizes myocardial damage during cardiac arrest and reperfusion.
- Older, complex patients require improved myocardial protection due to prolonged ischemia tolerance.
- Experimental studies show pharmacological agents can induce polarized arrest for superior protection.
Conclusions:
- Understanding of cardioplegia has evolved significantly.
- Polarized arrest represents a promising new frontier in myocardial protection.
- Further research into pharmacological agents for polarized arrest is warranted for complex cardiac surgeries.
Abstract:
The use of cardioplegia solution has substantially increased the safety of cardiac surgery. It protects the myocardium by inducing a rapid and complete diastolic arrest, minimizing myocardial energy requirements, preventing ischaemic damage during the arrest phase and minimizing or preventing reperfusion injury once coronary blood flow is restored. This article is a summary of important information that has accumulated in the literature about cardioplegia and describes how our understanding of cardioplegia has evolved. The basic principles of myocardial ischaemia and reperfusion injury and how they relate to myocardial protection are described. Blood and crystalloid cardioplegia are compared with respect to biochemical and physiological differences. Recent patient demographic changes, with surgeons operating on older, more complex patients who have more severe and diffuse disease, are discussed. This cohort of patients potentially requires prolonged elective ischaemia; hence, improved myocardial protection would be of benefit. We highlight areas of study that have demonstrated a new concept of myocardial protection, known as polarized arrest. Many pharmacological agents have been shown (in experimental studies) to have the ability to induce a polarized arrest and to provide improved protection.
Related Concept Videos
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
01:30Continuous Renal Replacement Therapy
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy